Posted on March 22, 2021 by Sitemaster
As Howard Wolinsky has been learning over the past few years, not all prostate cancer support groups are “equal” — in the sense that individual support group leaders may be seriously biased by their own personal experiences (which may have occurred many years ago). … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management | Tagged: bias, group, support | 2 Comments »
Posted on June 1, 2019 by Sitemaster
It was called “instrument bias” by Abraham Maslow and Abraham Kaplan, but for present purposes, we’ll call it “specialty bias” — over-reliance on the tool one is most familiar with. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: bias, instrument, radiation oncologist, RO, specialty, URO, urologist | 7 Comments »
Posted on November 1, 2016 by Sitemaster
A re-analysis of data from men participating in the placebo arms of the Prostate Cancer Prevention Trial (PCPT) and the Selenium and Vitamin E Cancer Prevention Trial (SELECT) has suggested a problem with bias in decisions about who gets biopsies during certain types of clinical trial. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Risk | Tagged: bias, biopsy, Prevention, risk, screening, testing | Leave a comment »
Posted on July 15, 2014 by Sitemaster
According to newly published data in JAMA Internal Medicine and discussed on the Reuters web site today, “physician characteristics may play a larger role than disease characteristics when it comes to how patients with low-risk prostate cancer are initially treated.” This won’t come as a big surprise to most experienced prostate cancer advocates. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Treatment | Tagged: bias, low risk, necessity, opinion, Treatment | 2 Comments »
Posted on November 14, 2013 by Sitemaster
A new article by Australian researchers in the Journal of the National Cancer Institute has suggested that the more widespread use of androgen deprivation therapy (ADT) among unscreened patients (controls) in the ERSPC and the Göteborg studies may have substantially affected patient mortality data in these trials. … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: bias, ERSPC, results, screening, Treatment | 6 Comments »
Posted on March 13, 2010 by Sitemaster
A recent article (and an associated editorial) in the Archives of Internal Medicine evaluated how visits to specialists and primary care physicians (PCPs) by men with localized prostate cancer are related to treatment choice. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment, Uncategorized | Tagged: bias, decision-making, opinion, physician, primary care, specialist | 1 Comment »
Posted on May 19, 2009 by Sitemaster
Today’s reports address:
- How German prostate cancer specialists would treat themselves
- Identification of patients appropriate for focal therapy
- Italian management of men with an elevated PSA level
- Triple therapy for men with T3a,b disease … READ MORE …
Filed under: Diagnosis, Management, Treatment | Tagged: bias, elevated PSA, focal therapy, Italy, T3 disease, training | Leave a comment »